or Try an Advanced Search...

    Technical Analysis for BNTX - BioNTech SE

    Grade Last Price % Change Price Change
    B 122.68 2.40% 2.88
    BNTX closed up 2.4 percent on Friday, October 4, 2024, on 63 percent of normal volume.
    6 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical BNTX trend table...
    Date Alert Name Type % Chg
    Multiple of Ten Bullish Other 0.00%
    Narrow Range Bar Range Contraction 2.40%
    Multiple of Ten Bearish Other 2.40%
    Inside Day Range Contraction 2.40%
    Wide Bands Range Expansion 2.40%
    Doji - Bullish? Reversal 3.09%
    Multiple of Ten Bearish Other 3.09%
    Wide Bands Range Expansion 3.09%
    MACD Bearish Signal Line Cross Bearish 2.29%
    Doji - Bearish? Reversal 2.29%
    Older End-of-Day Signals for BNTX ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 23 hours ago
    Rose Above Previous Day's High about 23 hours ago
    Up 2% about 23 hours ago
    Up 1% about 23 hours ago
    Possible NR7 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BNTX Chart by TradingView
    Basic chart:

    Profile

    BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Autoimmunity Biomarkers Allergy In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device

    Is BNTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 4 BioNTech's (NASDAQ:BNTX) investors will be pleased with their massive 749% return over the last five years
    Oct 3 BioNTech (BNTX) Presents at Innovation Series: AI Day
    Oct 1 ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
    Oct 1 BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
    Sep 25 As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech
    Sep 25 Covid-19 vaccine patent legal battle heading to Court of Appeal
    Sep 23 PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
    Sep 22 Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
    Sep 20 Pfizer/BioNTech new COVID shot endorsed by EMA advisory panel
    Sep 20 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
    See more BNTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 131.49
    52 Week Low 76.5301
    Average Volume 1,075,221
    200-Day Moving Average 94.07
    50-Day Moving Average 97.33
    20-Day Moving Average 115.04
    10-Day Moving Average 118.34
    Average True Range 4.66
    RSI (14) 70.93
    ADX 42.12
    +DI 37.60
    -DI 13.82
    Chandelier Exit (Long, 3 ATRs) 117.52
    Chandelier Exit (Short, 3 ATRs) 102.27
    Upper Bollinger Bands 130.43
    Lower Bollinger Band 99.65
    Percent B (%b) 0.75
    BandWidth 26.76
    MACD Line 6.87
    MACD Signal Line 7.16
    MACD Histogram -0.2838
    Fundamentals Value
    Market Cap 29.16 Billion
    Num Shares 238 Million
    EPS 12.15
    Price-to-Earnings (P/E) Ratio 10.10
    Price-to-Sales 3.38
    Price-to-Book 1.03
    PEG Ratio 0.04
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 129.36
    Resistance 3 (R3) 129.11 126.62 128.25
    Resistance 2 (R2) 126.62 124.92 126.75 127.88
    Resistance 1 (R1) 124.65 123.87 125.64 124.91 127.51
    Pivot Point 122.17 122.17 122.66 122.30 122.17
    Support 1 (S1) 120.20 120.47 121.18 120.45 117.85
    Support 2 (S2) 117.71 119.41 117.84 117.48
    Support 3 (S3) 115.74 117.71 117.11
    Support 4 (S4) 116.00